You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Hypertension 2015: Important Concepts in BP Control

  • Authors: Jan N. Basile, MD, FASH (Activity Chairman); William C. Cushman, MD, FASH; Michael A. Weber, MD, FASH
  • CME Released: 12/15/2015
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 12/15/2016
Start Activity


Target Audience and Goal Statement

This activity was developed for cardiologists, nephrologists, internists, primary care providers, and others involved in the diagnosis, treatment, and management of hypertension.

Hypertension (HTN) remains a major, modifiable risk factor for premature cardiovascular disease (CVD), yet CVD remains the most frequent cause of mortality in this country. Annual rates of HTN prevalence among American adults has remained approximately 30% over the past 10 years, which translates to more than 80 million adults today. Despite considerable improvements in both patient awareness and treatment, slightly more than 30% of all adults treated for HTN still remain uncontrolled, including those with resistant HTN. With newly enhanced management strategies, control to blood pressure goals may be achieved in more of these patients. This program will address best practices in uncomplicated HTN, combination therapy as initial therapy, and how to optimize BP control in patients with resistant HTN.

Upon completion of this activity, participants will be able to:

  1. Review the relative importance/evidence from clinical trials of effective BP reduction and clinical outcome improvement compared to a specific blood pressure lowering agent and outcome
  2. Evaluate the benefits of initial combination versus single agent antihypertensive therapy to control elevated blood pressure
  3. Delineate pharmacologic and clinical differences within the thiazide diuretic class
  4. Define resistant hypertension and its appropriate workup
  5. Recognize the importance of lifestyle modification, the evidence for the use of chlorthalidone vs hydrochlorothiazide, and mineralocorticoid receptor antagonism (spironolactone) in those with resistant hypertension


Disclosures

The opinions expressed in this educational activity are those of the faculty, and do not officially represent those of the American Society of Hypertension. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information. Further, should this activity contain discussion of published and/or investigational uses of agents that are not indicated by the FDA, faculty will disclose such discussion at the time of their presentation.


Authors

  • Jan N. Basile, MD, FASH, Chairman

    Professor of Medicine, Seinsheimer Cardiovascular Health Program, Medical University of South Carolina, Ralph H. Johnson VA Medical Center, Charleston, South Carolina

    Disclosures

    Disclosure: Jan N. Basile, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Amgen, Arbor, Eli Lilly, Forest, Janssen, Lundbeck, Medtronic, Novartis
    Served as a speaker or a member of a speakers bureau for: Arbor, Janssen
    Received grants for clinical research from: NHLBI (SPRINT)

  • William C. Cushman, MD, FASH

    Professor of Preventive Medicine, Medicine, and Physiology, The University of Tennessee College of Medicine, Chief, Preventive Medicine Section, at the Veterans Affairs (VA) Medical Center, Memphis, Tennessee

    Disclosures

    Disclosure: William C. Cushman, MD, has disclosed the following relevant financial relationships:
    Received grants for clinical research from: Eli Lily, Merck, NIH

  • Michael A. Weber, MD, FASH

    Professor of Medicine, SUNY Downstate College of Medicine, Brooklyn, New York

    Disclosures

    Disclosure: Michael A. Weber, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Ablative, Boston Scientific, Eli Lilly, Medtronic, Novartis, ReCor Medical Technology
    Served as a speaker or a member of a speakers bureau for: Arbor


Accreditation Statements

    For Physicians

  • The American Society of Hypertension, Inc., (ASH) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The American Society of Hypertension, Inc. (ASH) designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. In addition, you must complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

Hypertension 2015: Important Concepts in BP Control

Authors: Jan N. Basile, MD, FASH (Activity Chairman); William C. Cushman, MD, FASH; Michael A. Weber, MD, FASHFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME Released: 12/15/2015

Valid for credit through: 12/15/2016

processing....

This CME activity is based on the slides and lectures presented by the faculty at the symposium, Hypertension 2015: Important Concepts In BP Control, on May 18, 2015, at the Hilton New York Hotel in New York, New York.

This feature requires the newest version of Flash. You can download it here.